US EditionPharmamar's Success in Combining Two Drugs Against Lung Cancer Triggers His Actions
Summary by Galiciapress
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
PharmaMar has a close relationship with Galicia, since it was born as part of the Zeltia group, founded in 1939 in O Porriño (Pontevedra), and maintains there a key production center where it manufactures marine compounds with antitumor activity, such as the drug Yondelis. It has just applied for authorisation in the EU and the United States for a combination of two of its medicines, which has triggered its actions almost 4 percent in a matter o…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
